| Drug General Information |
| Drug ID |
D0JM0Z
|
| Former ID |
DNC002835
|
| Drug Name |
3-Methylpyridine
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C6H7N
|
| Canonical SMILES |
CC1=CN=CC=C1
|
| InChI |
1S/C6H7N/c1-6-3-2-4-7-5-6/h2-5H,1H3
|
| InChIKey |
ITQTTZVARXURQS-UHFFFAOYSA-N
|
| CAS Number |
CAS 108-99-6
|
| PubChem Compound ID |
|
| PubChem Substance ID |
81375, 839363, 3134273, 4783092, 7885289, 8155513, 10503689, 11452114, 15321090, 17389601, 24854159, 24887350, 24898513, 26697361, 35818752, 36260611, 37385514, 38230238, 46507201, 48415089, 48417209, 48420865, 48422960, 48424681, 49718209, 49854680, 53790506, 56369978, 57324643, 72213552, 75433060, 85173547, 87574620, 93617240, 103131958, 103178728, 103936092, 104316521, 104668285, 117421003, 118980213, 124890920, 125231095, 125337601, 126590223, 126650517, 126676672, 127115004, 127346126, 127346127
|
| Target and Pathway |
| Target(s) |
Stromelysin-1 |
Target Info |
Inhibitor |
[1]
|
|---|
| Collagenase 3 |
Target Info |
Inhibitor |
[1]
|
|
KEGG Pathway
|
TNF signaling pathway
|
|
Transcriptional misregulation in cancer
|
|
Rheumatoid arthritis
|
|
NetPath Pathway
|
IL1 Signaling Pathway
|
|
IL4 Signaling PathwayNetPath_13:IL1 Signaling Pathway
|
|
PANTHER Pathway
|
Plasminogen activating cascade
|
|
CCKR signaling map STP00004:Alzheimer disease-presenilin pathway
|
|
Pathway Interaction Database
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
p75(NTR)-mediated signaling
|
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signalingupa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
Reactome
|
Collagen degradation
|
|
Degradation of the extracellular matrix
|
|
Activation of Matrix Metalloproteinases
|
|
Assembly of collagen fibrils and other multimeric structures
|
|
EGFR Transactivation by GastrinR-HSA-1442490:Collagen degradation
|
|
WikiPathways
|
Activation of Matrix Metalloproteinases
|
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
|
Oncostatin M Signaling Pathway
|
|
Matrix MetalloproteinasesWP474:Endochondral Ossification
|
|
AGE/RAGE pathway
|
|
Matrix Metalloproteinases
|
| References |
| REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
|---|
